Hypertriglyceridemia-induced acute pancreatitis: clinical considerations

Bibliography

• Gan SI, Edwards AL, Symonds CJ, Beck PL. Hypertriglyceridemia-induced pancreatitis: a case-based review. World J. Gastroenterol. 12, 7197–7202 (2006)
   Google Scholar
• Waldthaler A, Schutte K, Malfertheiner P. Causes and mechanisms in acute pancreatitis. Dig. Dis. 28, 364–372 (2010)
   Google Scholar
• Morinville VD, Husain SZ, Bai H et al.; on behalf of the INSPPIRE Group. Definitions of pediatric pancreatitis and survey of current clinical practices: report from INSPPIRE (International Study Group of Pediatric Pancreatitis: in Search for a Cure). J. Pediatr. Gastroenterol. Nutr. doi:10.1097/ MPG.0b013e31824f1516 (2012) (Epub ahead of print)
   Google Scholar
• Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol. Clin. North Am. 19, 783–791 (1990)
   Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421 (2002)
   Google Scholar
• Lloret Linares C, Pelletier AL, Czernichow S et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 37, 13–12 (2008)
   Google Scholar
• Sandhu S, Al-Sarraf A, Taraboanta C, Frohlich J, Francis GA. Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study. Lipids Health Dis. 10, 157 (2011)
   Google Scholar
• Deng LH, Xue P, Xia Q, Yang XN, Wan MH. Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis. World J. Gastroenterol. 14, 4558–4561 (2008)
   Google Scholar
• Balachandra S, Virlos IT, King NK, Siriwardana HP, France MW, Siriwardena AK. Hyperlipidaemia and outcome in acute pancreatitis. Int. J. Clin. Pract. 60, 156–159 (2006)
   Google Scholar
• Hofbauer B, Friess H, Weber A et al. Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut 38, 753–758 (1996)
   Google Scholar
• Kim BK, Kim MJ, Chang WC, Yoo KH, Shin YG, Chung CH. Recurrent acute pancreatitis in a patient with type IIb hyperlipoproteinemia: a case report and review of the literature in Korea. Yonsei Med. J. 47, 144–147 (2006)
   Google Scholar
• Kolovou GD, Anagnostopoulou KK, Kostakou PM, Bilianou H, Mikhailidis DP. Primary and secondary hypertriglyceridaemia. Curr. Drug Targets 10, 336–343 (2009)
   Google Scholar
• Fojo SS, Brewer HB. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C?II. J. Intern. Med. 231, 669–677 (1992)
   Google Scholar
• Keilson LM, Vary CP, Sprecher DL, Renfrew R. Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene. Ann. Intern. Med. 124, 425–428 (1996)
   Google Scholar
• Coca-Prieto I, Valdivielso P, Olivecrona G et al. Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis. BMC Gastroenterol. 9, 46 (2009)
   Google Scholar
• Ivanova R, Puerta S, Garrido A et al. Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis. Hepatobiliary Pancreat. Dis Int. 11, 96–101 (2012)
   Google Scholar
• Van de Wiel A. The effect of alcohol on postprandial and fasting triglycerides. Int. J. Vasc. Med. 2012, 862504 (2012)
   Google Scholar
• Bessembinders K, Wielders J, van de Wiel A. Severe hypertriglyceridemia influenced by alcohol (SHIBA). Alcohol Alcohol. 46, 113–116 (2011)
   Google Scholar
• Papadakis EP, Sarigianni M, Mikhailidis DP, Mamopoulos A, Karagiannis V. Acute pancreatitis in pregnancy: an overview. Eur. J. Obstet. Gynecol. Reprod. Biol. 159, 261–266 (2011)
   Google Scholar
• Filippatos TD, Liberopoulos EN, Pavlidis N, Elisaf MS, Mikhailidis DP. Effects of hormonal treatment on lipids in patients with cancer. Cancer Treat Rev. 35, 175–184 (2009)
   Google Scholar
• Perego E, Scaini A, Romano F, Franciosi C, Uggeri F. Estrogen-induced severe acute pancreatitis in a male. JOP 5, 353–356 (2004)
   Google Scholar
• Elisaf MS, Nakou K, Liamis G, Pavlidis NA. Tamoxifen-induced severe hypertriglyceridemia and pancreatitis. Ann. Oncol. 11, 1067–1069 (2000)
   Google Scholar
• Mikhailidis D, Ganotakis E, Georgoulias V, Vallance D, Winder A. Tamoxifen-induced hypertriglyceridaemia. Oncol. Rep. 4, 625–628 (1997)
   Google Scholar
• Jamshidi M, Obermeyer RJ, Govindaraj S, Garcia A, Ghani A. Acute pancreatitis secondary to isotretinoin-induced hyperlipidemia. J. Okla. State Med. Assoc. 95, 79–80 (2002)
   Google Scholar
• Jiang CY, Han TQ, Feng FL, Kong L, Cai XX, Zhang SD. Clinical characteristics of acute pancreatitis patients with elevated serum triglyceride concentration. Chin. J. Dig. Dis 6, 43–46 (2005)
   Google Scholar
• Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J. Clin. Gastroenterol. 36, 54–62 (2003)
   Google Scholar
• Rollan A, Guzman S, Pimentel F, Nervi F. Catabolism of chylomicron remnants in patients with previous acute pancreatitis. Gastroenterology 98, 1649–1654 (1990)
   Google Scholar
• Guzman S, Nervi F, Llanos O, Leon P, Valdivieso V. Impaired lipid clearance in patients with previous acute pancreatitis. Gut 26, 888–891 (1985)
   Google Scholar
• H'ckerstedt K. The Ranson criteria for acute pancreatitis. Acta Chir. Scand. 152, 717 (1986)
   Google Scholar
• Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab. Res Rev. 28(4), 338–342 (2011)
   Google Scholar
• Kadikoylu G, Yukselen V, Yavasoglu I, Coskun A, Karaoglu AO, Bolaman Z. Emergent therapy with therapeutic plasma exchange in acute recurrent pancreatitis due to severe hypertriglyceridemia. Transfus. Apher. Sci. 43, 285–289 (2010)
   Google Scholar
• Kakafika A, Papadopoulos V, Mimidis K, Mikhailidis DP. Coagulation, platelets, and acute pancreatitis. Pancreas 34, 15–20 (2007)
   Google Scholar
• Jain D, Zimmerschied J. Heparin and insulin for hypertriglyceridemia-induced pancreatitis: case report. ScientificWorldJournal 9, 1230–1232 (2009)
   Google Scholar
• Twilla JD, Mancell J. Hypertriglyceridemiainduced acute pancreatitis treated with insulin and heparin. Am. J. Health Syst. Pharm. 69, 213–216 (2012)
   Google Scholar
• Loh JA, Rickels MR, Williams J, Iqbal N. Total parenteral nutrition in management of hyperlipidemic pancreatitis during pregnancy. Endocr. Pract. 11, 325–330 (2005)
   Google Scholar
• Chapman MJ, Ginsberg HN, Amarenco P et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur. Heart J. 32, 1345–1361 (2011)
   Google Scholar
• Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 141, 150–156 (2011)
   Google Scholar
• Athyros VG, Giouleme OI, Nikolaidis NL et al. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis. J. Clin. Gastroenterol. 34, 472–475 (2002)
   Google Scholar
• Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS. Fibrate-associated adverse effects beyond muscle and liver toxicity. Curr. Pharm. Des. 14, 574–587 (2008)
   Google Scholar
• Goldberg RB, Jacobson TA. Effects of niacin on glucose control in patients with dyslipidemia. Mayo Clin. Proc. 83, 470–478 (2008)
   Google Scholar
• Kostapanos MS, Milionis HJ, Filippatos TD et al. A 12?week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia. Clin. Ther. 29, 1403–1414 (2007)
   Google Scholar
• Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL. Metaanalysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr. Med. Res. Opin 23, 2009–2026 (2007).
   Google Scholar